Waters (WAT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Voting matters and shareholder proposals
Election of eleven directors to serve for the ensuing year and until successors are elected.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote to approve executive officer compensation on a non-binding basis.
Consideration of any other matters properly brought before the meeting or adjournments.
Board of directors and corporate governance
Eleven nominees listed for election to the board, including individuals with diverse backgrounds and expertise.
Executive compensation and say-on-pay
Shareholders to vote on a non-binding, advisory basis regarding executive officer compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Waters
- 2026 guidance projects $6.4B–$6.5B revenue and 9–10% EPS growth after BD acquisition.WAT
Q4 202514 Apr 2026 - Strong 2025 results, strategic acquisition, and robust governance drive long-term growth.WAT
Proxy filing9 Apr 2026 - BD integration advances with focus on execution, margin gains, and strong core growth outlook.WAT
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Q2 beat guidance, with resilient margins and a cautious full-year outlook amid FX and demand headwinds.WAT
Q2 20242 Feb 2026 - Strong growth in consumables and innovation, with China and efficiency driving future gains.WAT
Jefferies Global Healthcare Conference1 Feb 2026 - Q3 2024 sales and EPS exceeded guidance, with raised full-year outlook and strong recurring revenue.WAT
Q3 202417 Jan 2026 - Transformation and BD deal drive industry-leading growth, innovation, and synergy realization.WAT
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Q3 growth, China stabilization, and new drivers like GLP-1s and PFAS fuel a positive outlook.WAT
7th Annual Evercore ISI HealthCONx Conference11 Jan 2026 - Transformation and innovation drive growth, margin gains, and set up strong 2025 outlook.WAT
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026